Balancing thromboembolism and bleeding risks: insights from anticoagulation for prosthetic heart valves.
Tay
Kok-Hoon
KH
University Department of Medicine, City Hospital, Birmingham, UK.
Lane
Deirdre A
DA
University Department of Medicine, City Hospital, Birmingham, UK.
Lip
Gregory Y H
GYH
University Department of Medicine, City Hospital, Birmingham, UK. Electronic address: g.y.h.lip@bham.ac.uk.
D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology*; D006801:Humans; D008943:Mitral Valve; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; C446540:thienopyridine; D001241:Aspirin